1-4 of 4
Roger Lyons, MD
Close
Sort by
Journal Articles

Once-Weekly Carfilzomib with Dexamethasone Demonstrated Promising Safety and Efficacy in Patients with Relapsed or Refractory Multiple Myeloma Regardless of Age and Prior Bortezomib Exposure

Jesus G. Berdeja, MD, Robert M. Rifkin, MD, Roger Lyons, MD, Hui Yang, Anita Zahlten-Kuemeli, Sanjay K. Aggarwal, Karim Iskander, PhD, James Berenson, MD
Journal: Blood
Blood (2016) 128 (22): 2129.
https://doi.org/10.1182/blood.V128.22.2129.2129
Published: 2016
Journal Articles

The Efficacy and Safety of Continued Hydroxyurea Therapy Versus Switching to Ruxolitinib in Patients with Polycythemia Vera: A Randomized, Double-Blind, Double-Dummy, Symptom Study (RELIEF)

Ruben Mesa, MD, Alessandro M. Vannucchi, MD, Abdulraheem Yacoub, MD MB, Pierre Zachee, MD PhD, Mamta Garg, MD FRCP, FRCPath, Roger Lyons, MD, Silwan Chedid, MD, Steffen Koschmieder, MD, Ciro Rinaldi, MD PhD, Jennifer Byrne, MB, ChB, PhD FRCP, FRCPath, Yasmin Hasan, MD, Francesco Passamonti, MD, Srdan Verstovsek, MD PhD, Deborah Hunter, PhD, Mark M Jones, MD, Shui He, PhD, Alex Morozov, MD PhD, Bruno Martino, MD
Journal: Blood
Blood (2014) 124 (21): 3168.
https://doi.org/10.1182/blood.V124.21.3168.3168
Published: 2014
Journal Articles

The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndrome (MDS).

Hagop M. Kantarjian, MD, Francis Giles, MD, FRCPI, FRCPath, Alan F. List, MD, Roger Lyons, MD, Sherry Price, BSN, Robert Deuson, PhD, Joseph Leveque, MD
Journal: Blood
Blood (2006) 108 (11): 2617.
https://doi.org/10.1182/blood.V108.11.2617.2617
Published: 2006
Journal Articles

Azacitidine (Vidaza®) Treatment Response Assessed Using Three Alternative Dosing Schedules in Patients with Myelodysplastic Syndromes (MDS).

Roger Lyons, MD, Thomas Cosgriff, MD, Sanjiv Modi, MD, Linda Lintz, BA, C.L. Beach, PharmD, Jay T. Backstrom, MD, MPH
Journal: Blood
Blood (2005) 106 (11): 2517.
https://doi.org/10.1182/blood.V106.11.2517.2517
Published: 2005